EI
LLY icon

Ethic Inc’s Eli Lilly LLY Stock Holding History

Ethic Inc’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.8M Buy
84,534
+2,868
+4% +$2.91M 1.22% 8
2025
Q4 		$87.8M Buy
81,666
+5,758
+8% +$5.51M 1.35% 9
2025
Q3 		$57.9M Sell
75,908
-405
-0.5% -$301K 0.95% 11
2025
Q2 		$59.2M Buy
76,313
+125
+0.2% +$97.1K 1.06% 11
2025
Q1 		$61.3M Buy
76,188
+42
+0.1% +$34.9K 1.24% 8
2024
Q4 		$58.8M Buy
76,146
+6,379
+9% +$5.28M 1.19% 9
2024
Q3 		$54.3M Sell
69,767
-4,336
-6% -$3.9M 1.37% 7
2024
Q2 		$67.1M Buy
74,103
+4,336
+6% +$3.47M 1.57% 7
2024
Q1 		$54.3M Buy
69,767
+7,255
+12% +$5.16M 1.37% 7
2023
Q4 		$36.4M Buy
62,512
+1,940
+3% +$1.13M 1.08% 8
2023
Q3 		$32.5M Buy
60,572
+5,059
+9% +$2.61M 1.14% 8
2023
Q2 		$26M Buy
55,513
+921
+2% +$386K 0.97% 8
2023
Q1 		$18.7M Buy
54,592
+5,514
+11% +$1.86M 0.76% 12
2022
Q4 		$18M Buy
49,078
+6,023
+14% +$2.14M 0.97% 8
2022
Q3 		$13.9M Buy
43,055
+5,866
+16% +$1.86M 0.95% 7
2022
Q2 		$12.1M Buy
37,189
+21,275
+134% +$6.39M 0.84% 12
2022
Q1 		$4.56M Sell
15,914
-9,729
-38% -$2.5M 0.31% 74
2021
Q4 		$7.08M Buy
25,643
+13,533
+112% +$3.43M 0.55% 28
2021
Q3 		$2.8M Buy
12,110
+3,116
+35% +$769K 0.29% 82
2021
Q2 		$2.06M Sell
8,994
-4,236
-32% -$851K 0.25% 95
2021
Q1 		$2.47M Buy
13,230
+1,728
+15% +$338K 0.44% 42
2020
Q4 		$1.94M Buy
11,502
+2,410
+27% +$360K 0.51% 35
2020
Q3 		$1.35M Buy
9,092
+1,256
+16% +$194K 0.51% 37
2020
Q2 		$1.29M Buy
7,836
+1,234
+19% +$189K 0.73% 31
2020
Q1 		$916K Buy
6,602
+784
+13% +$108K 0.76% 25
2019
Q4 		$765K Buy
+5,818
New +$674K 0.56% 43

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ethic Inc's LLY Position: Q1 2026 in Review

Ethic Inc increased its Eli Lilly (LLY) stake by 3.5% in Q1 2026, buying an estimated $2.91M and bringing the position to 84,534 shares worth $77.8M. The position accounts for 1.22% of the portfolio, ranked #8.

Ethic Inc first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $87.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ethic Inc held 84,534 shares of Eli Lilly worth $77.8M as of Q1 2026.
  • Ethic Inc bought 2,868 Eli Lilly shares in Q1 2026, an estimated $2.91M.
  • Eli Lilly made up 1.22% of Ethic Inc's portfolio in Q1 2026, its #8 holding.
  • Ethic Inc first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • Ethic Inc's Eli Lilly position peaked at $87.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.